PureTide
← Back to catalog
BBG70 (Glow) vial with the PureTide house label

Cosmetic · Placeholder catalog data

BBG70 (Glow)

Also known as BPC-157 + GHK-Cu + TB-500

A 70 mg multi-peptide blend combining BPC-157 10 mg, GHK-Cu 50 mg, and TB-500 10 mg in one vial. Positioned for pathway-combination studies spanning connective tissue, fibroblast signaling, and tissue remodeling.

255 credits

Ships in 7 business days

Paid from your credit pool at checkout. Bulk quantities discount automatically.

Customize this product

Available variants

Pricing and fulfillment information is placeholder data.

AmountSKUCreditsMSRPAvailabilityMargin estimate
70 mgPTS-BBG70-7051 credits$1297 business days60% estimate

Margin estimate treats 1 credit as $1 and compares estimated wholesale credit cost with placeholder MSRP. It excludes shipping, taxes, and other costs.

Buy more, save more

Quantity breaks apply per line item and are deducted automatically at checkout.

Quantity per lineDiscountExample (70 mg unit)
10+ units5% off10 × 51 credits485 credits
25+ units10% off25 × 51 credits1,148 credits
50+ units15% off50 × 51 credits2,168 credits
100+ units20% off100 × 51 credits4,080 credits

Specifications

Formula
Composite blend of BPC-157, GHK-Cu, and TB-500
Molecular weight
6784.88 g/mol
Sequence
BPC-157 (15 aa) · GHK-Cu tripeptide complex · TB-500 fragment
Purity
Each component ≥99%
Appearance
Lyophilized peptide blend
Storage
Store lyophilized at −20 °C, protected from light and moisture

Quality record

COA status

COA listed

Lot PTS-BBG70-2607

Placeholder reference. Verify the active lot before ordering.

Research background

BBG70 Glow is a combined peptide stack built around three research ingredients that are often discussed together in connective tissue and aesthetic-regeneration circles: BPC-157, GHK-Cu, and TB-500. The blend is intended as a single-vial reference for researchers studying overlapping repair, fibroblast, and extracellular matrix pathways rather than isolating one peptide at a time.

Across the underlying literature, BPC-157 has been examined in tendon, ligament, gut, and angiogenic models; GHK-Cu has been studied in fibroblast activation, collagen signaling, and dermal remodeling; and Thymosin β4 / TB-500 has been explored in migration, wound repair, and actin-mediated regeneration models.

Supplied as a research-use-only stack for pathway-combination studies and internal formulation work. Not supplied for human or veterinary use.

Mechanism: The stack is positioned around complementary pathway coverage: BPC-157 for cytoprotective and angiogenic signaling, GHK-Cu for copper-peptide and fibroblast activity, and TB-500 for actin-mediated migration and tissue-repair signaling.

Research use only

For research use only. Not for human or veterinary use.